Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
35
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Successful treatment of recurrent esophageal squamous cell carcinoma with muscle metastasis using capecitabine and cetuximab

, DO, MScORCID Icon, , MD, , MD & , MD
Pages 834-836 | Received 27 Apr 2022, Accepted 07 Jul 2022, Published online: 25 Jul 2022
 

Abstract

Esophageal cancer (EC) is a relatively rare malignancy in the United States, although it is associated with high morbidity and mortality. More than 90% of EC cancer-related mortality is due to distant metastasis, most commonly to the liver, lungs, bone, and brain. Although EC has a high tendency for random dissemination, it rarely metastasizes to the muscles and soft tissue. Here, we report a rare case of a patient with recurrent esophageal squamous cell carcinoma metastasis to his left thigh musculature, initially suspected to be a soft tissue sarcoma on magnetic resonance imaging. The patient did not tolerate standard chemotherapy with epirubicin, oxaliplatin, and capecitabine and was subsequently successfully treated with neoadjuvant radiotherapy, surgery, and adjuvant chemotherapy with capecitabine and cetuximab for 2 years and capecitabine alone for 1 year.

Log in via your institution

Log in to Taylor & Francis Online

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 37.00 Add to cart

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.